Novadiscovery
Riad KAHOUL is an experienced executive manager specializing in biostatistics, modeling, and simulation within the pharmaceutical industry. Currently serving as the Executive Manager and Head of Biostatistics at Nova In Silico since June 2024, Riad previously held a similar executive role at Novadiscovery from July 2010 to June 2024, focusing on model-informed drug development and personalized medicine. Riad's earlier career includes positions as an R&D Scientist at CNRS and EZUS LYON S.A., where statistical analysis and disease modeling were key responsibilities. Additionally, Riad has a medical background as a Medical Doctor at CHU Ibn Rochd. Academic qualifications include a Ph.D. in Pharmacology and multiple master's degrees from Université Claude Bernard Lyon 1 and Universitat de Barcelona, emphasizing expertise in pharmacology, mathematics, and computer science for life sciences.
This person is not in any offices
Novadiscovery
novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enablingscientists and biotech, pharma companies to predict drug efficacy and create the target combination.